Tecson, Vrianna L.
HRN: 28-93-49 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2026
AMPICILLIN 500MG (VIAL)
05/01/2026
05/08/2026
IV
150mg
Q12hours
T/c Neonatal Sepsis
Checking Initial Appropriateness
05/01/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/01/2026
05/08/2026
IV
45mg
Q24hours
T/c Neonatal Sepsis
Checking Initial Appropriateness